JP Morgan Chase
RMTI icon

JP Morgan Chase’s Rockwell Medical RMTI Stock Holding History

JP Morgan Chase’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30 Hold
4
– – ﹤0.01% 7390
2025
Q4 		$29 Hold
4
– – ﹤0.01% 7280
2025
Q3 		$42 Hold
4
– – ﹤0.01% 7236
2025
Q2 		$30 Hold
4
– – ﹤0.01% 6934
2025
Q1 		$40 Sell
4
-342
-99% -$6.21K ﹤0.01% 7022
2024
Q4 		$7.06K Sell
346
-4,361
-93% -$127K ﹤0.01% 6451
2024
Q3 		$187K Buy
4,707
+4,703
+117,575% +$127K ﹤0.01% 5435
2024
Q2 		$62 Hold
4
– – ﹤0.01% 6980
2024
Q1 		$58 Hold
4
– – ﹤0.01% 7010
2023
Q4 		$66 Hold
4
– – ﹤0.01% 7168
2023
Q3 		$73 Hold
4
– – ﹤0.01% 6948
2023
Q2 		$191 Hold
4
– – ﹤0.01% 6638
2023
Q1 		$0 Hold
4
– – ﹤0.01% 7153
2022
Q4 		$0 Hold
4
– – ﹤0.01% 6925
2022
Q3 		$0 Hold
4
– – ﹤0.01% 6799
2022
Q2 		$0 Hold
4
– – ﹤0.01% 6817
2022
Q1 		$0 Hold
4
– – ﹤0.01% 6946
2021
Q4 		$0 Hold
4
– – ﹤0.01% 6913
2021
Q3 		$0 Sell
4
-2,129
-100% -$162K ﹤0.01% 6738
2021
Q2 		$213K Buy
2,133
+912
+75% +$94.1K ﹤0.01% 5213
2021
Q1 		$155K Sell
1,221
-523
-30% -$77.3K ﹤0.01% 5249
2020
Q4 		$194K Buy
1,744
+1,304
+296% +$146K ﹤0.01% 4817
2020
Q3 		$50K Buy
440
+231
+111% +$40K ﹤0.01% 4934
2020
Q2 		$45K Buy
209
+29
+16% +$6.85K ﹤0.01% 4854
2020
Q1 		$41K Sell
180
-4
-2% -$1.14K ﹤0.01% 4782
2019
Q4 		$49K Hold
184
– – ﹤0.01% 5134
2019
Q3 		$56K Buy
184
+45
+32% +$13.8K ﹤0.01% 5132
2019
Q2 		$46K Buy
139
+34
+32% +$17.3K ﹤0.01% 5198
2019
Q1 		$66K Sell
105
-5
-5% -$2.28K ﹤0.01% 5032
2018
Q4 		$27K Buy
110
+10
+10% +$3.98K ﹤0.01% 5263
2018
Q3 		$46K Buy
100
+12
+14% +$5.81K ﹤0.01% 5227
2018
Q2 		$48K Sell
88
-3
-3% -$1.8K ﹤0.01% 5090
2018
Q1 		$52K Sell
91
-6
-6% -$3.79K ﹤0.01% 4802
2017
Q4 		$62K Buy
97
+94
+3,133% +$66.2K ﹤0.01% 4825
2017
Q3 		$3K Hold
3
– – ﹤0.01% 4845
2017
Q2 		$3K Hold
3
– – ﹤0.01% 4817
2017
Q1 		$2K Sell
3
-27
-90% -$17.8K ﹤0.01% 4959
2016
Q4 		$21K Sell
30
-234
-89% -$162K ﹤0.01% 4696
2016
Q3 		$195K Sell
264
-21
-7% -$17K ﹤0.01% 3695
2016
Q2 		$237K Sell
285
-2,613
-90% -$2.43M ﹤0.01% 3667
2016
Q1 		$2.39M Sell
2,898
-28
-1% -$22K ﹤0.01% 2607
2015
Q4 		$3.3M Buy
2,926
+44
+2% +$51.2K ﹤0.01% 2470
2015
Q3 		$2.44M Buy
2,882
+2,575
+839% +$3.73M ﹤0.01% 2642
2015
Q2 		$543K Sell
307
-43
-12% -$54.7K ﹤0.01% 3532
2015
Q1 		$422K Buy
350
+25
+8% +$29.3K ﹤0.01% 3601
2014
Q4 		$368K Buy
325
+32
+11% +$32.8K ﹤0.01% 3787
2014
Q3 		$295K Buy
293
+112
+62% +$127K ﹤0.01% 3866
2014
Q2 		$239K Sell
181
-54
-23% -$65K ﹤0.01% 3330
2014
Q1 		$327K Buy
235
+3
+1% +$3.9K ﹤0.01% 3262
2013
Q4 		$266K Buy
232
+25
+12% +$34.5K ﹤0.01% 3730
2013
Q3 		$259K Buy
207
+2
+1% +$1.36K ﹤0.01% 3943
2013
Q2 		$81K Buy
+205
New +$86.9K ﹤0.01% 4196

Other funds holding RMTI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

JP Morgan Chase's RMTI Position: Q1 2026 in Review

JP Morgan Chase held its Rockwell Medical (RMTI) position steady in Q1 2026 at 4 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #7390.

JP Morgan Chase first reported a position in RMTI in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.3M in Q4 2015. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • JP Morgan Chase held 4 shares of Rockwell Medical worth $30 as of Q1 2026.
  • JP Morgan Chase left its Rockwell Medical share count unchanged in Q1 2026.
  • Rockwell Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7390 holding.
  • JP Morgan Chase first reported a position in Rockwell Medical in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Rockwell Medical position peaked at $3.3M in Q4 2015.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.